Cardioprotective effects of hesperetin against doxorubicin-induced oxidative stress and DNA damage in rat

Cardiovascular Toxicology

Volumn 11, Issue 3, 2011, Pages 215-225

  Trivedi, P P ^a   Kushwaha, S ^a   Tripathi, D N ^a   Jena, G B ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Apoptosis; Doxorubicin; Heart; Hesperetin; Oxidative stress

Indexed keywords

CASPASE 3; DOXORUBICIN; GLUTATHIONE; HESPERETIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MALONALDEHYDE; MITOGEN ACTIVATED PROTEIN KINASE P38;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CARDIOTOXICITY; CELL STRUCTURE; COMET ASSAY; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; DRUG EFFECT; GENOTOXICITY; HEART MUSCLE CELL; HEART PROTECTION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CONTENT; RAT;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIOXIDANTS; APOPTOSIS; CASPASE 3; COMET ASSAY; CYTOPROTECTION; DISEASE MODELS, ANIMAL; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; GLUTATHIONE; HEART DISEASES; HESPERIDIN; IN SITU NICK-END LABELING; MALE; MALONDIALDEHYDE; MYOCYTES, CARDIAC; NF-KAPPA B; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

ANIMALIA; RATTUS;

EID: 80054898863     PISSN: 15307905     EISSN: 15590259     Source Type: Journal    
DOI: 10.1007/s12012-011-9114-2     Document Type: Article

References (50)

1. Kim, J. C., Kim, K. H., & Chung, M. K. (1999). Testicular cytotoxicity of DA-125, a new anthracycline anticancer agent, in rats. Reproductive Toxicology, 13, 391-397.
2. Alkreathy, H., Damanhouri, Z. A., Ahmed, N., Slevin, M., Ali, S. S., & Osman, A. M. (2010). Aged garlic extract protects against doxorubicin-induced cardiotoxicity in rats. Food and Chemical Toxicology, 48, 951-956.
3. Ludke, A. R., Al-Shudiefat, A. A., Dhingra, S., Jassal, D. S., & Singal, P. K. (2009). A concise description of cardioprotective strategies in doxorubicin-induced cardiotoxicity. Canadian Journal of Physiology and Pharmacology, 87, 756-763.
4. Fan, G. C., Zhou, X., Wang, X., Song, G., Qian, J., Nicolaou, P., et al. (2008). Heat shock protein 20 interacting with phosphory-lated Akt reduces doxorubicin-triggered oxidative stress and cardiotoxicity. Circulation Research, 103, 1270-1279.
5. Simoncikova, P., Ravingerova, T., & Barancik, M. (2008). The effect of chronic doxorubicin treatment on mitogen-activated protein kinases and heat stress proteins in rat hearts. Physiological Research, 57(Suppl 2), S97-S102.
6. Liu, Z., Song, X. D., Xin, Y., Wang, X. J., Yu, H., Bai, Y. Y., et al. (2009). Protective effect of chrysoeriol against doxorubicin-induced cardiotoxicity in vitro. Chinese Medical Journal, 122, 2652-2656.
7. Chandran, K., Aggarwal, D., Migrino, R. Q., Joseph, J., McAllister, D., Konorev, E. A., et al. (2009). Doxorubicin inactivates myocardial cytochrome c oxidase in rats: Cardioprotection by Mito-Q. Biophysical Journal, 96, 1388-1398.
8. Li, L., Pan, Q., Han, W., Liu, Z., Li, L., & Hu, X. (2007). Schisandrin B prevents doxorubicin-induced cardiotoxicity via enhancing glutathione redox cycling. Clinical Cancer Research, 13, 6753-6760. (Pubitemid 350206813)
9. Van Dalen, E. C., van der Pal, H. J., Caron, H. N., & Kremer, L. C. (2009). Different dosage schedules for reducing cardio-toxicity in cancer patients receiving anthracycline chemotherapy. Cochrane Database of Systematic Reviews, 4, CD00 5008.
10. Aiken, M. J., Suhag, V., Garcia, C. A., Acio, E., Moreau, S., Priebat, D. A., et al. (2009). Doxorubicin-induced cardiac toxicity and cardiac rest gated blood pool imaging. Clinical Nuclear Medicine, 34, 762-767.
11. Gil-Izquierdo, A., Gil, M. I., Ferreres, F., & Tomas-Barberan, F. A. (2001). In vitro availability of flavonoids and other phenolics in orange juice. Journal of Agricultural and Food Chemistry, 49, 1035-1041. (Pubitemid 32172666)
12. Ameer, B., Weintraub, R. A., Johnson, J. V., Yost, R. A., & Rouseff, R. L. (1996). Flavanone absorption after naringin, hes-peridin, and citrus administration. Clinical Pharmacology and Therapeutics, 60, 34-40. (Pubitemid 26279218)
13. Lee, N. K., Choi, S. H., Park, S. H., Park, E. K., & Kim, D. H. (2004). Antiallergic activity of hesperidin is activated by intestinal microflora. Pharmacology, 71, 174-180.
14. Manach, C., Morand, C., Gil-Izquierdo, A., Bouteloup-Demange, C., & Remesy, C. (2003). Bioavailability in humans of the flava-nones hesperidin and narirutin after the ingestion of two doses of orange juice. European Journal of Clinical Nutrition, 57, 235-242. (Pubitemid 36240474)
15. Galati, E. M., Trovato, A., Kirjavainen, S., Forestieri, A. M., Rossitto, A., & Monforte, M. T. (1996). Biological effects of hesperidin, a Citrus flavonoid. (Note III): Antihypertensive and diuretic activity in rat. Farmaco, 51, 219-221. (Pubitemid 26162092)
16. Garg, A., Garg, S., Zaneveld, L. J., & Singla, A. K. (2001). Chemistry and pharmacology of the Citrus bioflavonoid hesper-idin. Phytotherapy Research, 15, 655-669. (Pubitemid 34016792)
17. Aranganathan, S., Selvam, J. P., & Nalini, N. (2008). Effect of hesperetin, a citrus flavonoid, on bacterial enzymes and carcinogen-induced aberrant crypt foci in colon cancer rats: A dose-dependent study. Journal of Pharmacy and Pharmacology, 60, 1385-1392.
18. Choi, E. J., & Ahn, W. S. (2008). Neuroprotective effects of chronic hesperetin administration in mice. Archives of Pharmacal Research, 31, 1457-1462.
19. Dimpfel, W. (2006). Different anticonvulsive effects of hesperi-din and its aglycone hesperetin on electrical activity in the rat hippocampus in vitro. Journal of Pharmacy and Pharmacology, 58, 375-379. (Pubitemid 43344581)
20. Guthrie, N., & Carroll, K. K. (1998). Inhibition of mammary cancer by citrus flavonoids. Advances in Experimental Medicine and Biology, 439, 227-236. (Pubitemid 28429019)
21. Miyake, Y., Yamamoto, K., Tsujihara, N., & Osawa, T. (1998). Protective effects of lemon flavonoids on oxidative stress in diabetic Rats. Lipids, 33, 689-695. (Pubitemid 28328798)
22. Saija, A., Scalese, M., Lanza, M., Marzullo, D., Bonina, F., & Castelli, F. (1995). Flavonoids as antioxidant agents: Importance of their interaction with biomembranes. Free Radical Biology and Medicine, 19, 481-486.
23. Nagi, M. N., & Mansour, M. A. (2000). Protective effect of thymoquinone against doxorubicin-induced cardiotoxicity in rats: A possible mechanism of protection. Pharmacological Research, 41, 283-289. (Pubitemid 30663132)
24. Aranganathan, S., Selvam, J. P., & Nalini, N. (2009). Hesperetin exerts dose dependent chemopreventive effect against 1, 2-dimethyl hydrazine induced rat colon carcinogenesis. Investi-gational New Drugs, 27, 203-213.
25. Ohkawa, H., Ohishi, N., & Yagi, K. (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry, 95, 351-358. (Pubitemid 9194347)
26. Moron, M. S., Depierre, J. W., & Mannervik, B. (1979). Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochimica et Biophysica Acta, 582, 67-78. (Pubitemid 9065588)
27. Lowry, O. H., Rosebrough, N. J., Farr, A. L., & Randall, R. J. (1951). Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 193, 265-275.
28. Vikram, A., Tripathi, D. N., Ramarao, P., & Jena, G. B. (2008). Intervention of D-glucose ameliorates the toxicity of streptozo-tocin in accessory sex organs of rat. Toxicology and Applied Pharmacology, 226, 84-93. (Pubitemid 350235584)
29. Kasamatsu, T., Kohda, K., & Kawazoe, Y. (1996). Comparison of chemically induced DNA breakage in cellular and subcellular systems using the comet assay. Mutation Research, 369, 1-6. (Pubitemid 26242791)
30. Speit, G., & Hartmann, A. (1999). The comet assay (single-cell gel test). A sensitive genotoxicity test for the detection of DNA damage and repair. Methods in Molecular Biology, 113, 203-212.
31. Singh, N. P. (2000). A simple method for accurate estimation of apoptotic cells. Experimental Cell Research, 256, 328-337. (Pubitemid 30211196)
32. Lebrecht, D., Geist, A., Ketelsen, U. P., Haberstroh, J., Setzer, B., & Walker, U. A. (2007). Dexrazoxane prevents doxorubicin-induced long-term cardiotoxicity and protects myocardial mitochondria from genetic and functional lesions in rats. British Journal of Psychiatry, 151, 771-778. (Pubitemid 47075325)
33. Simunek, T., Sterba, M., Popelova, O., Adamcova, M., Hrdina, R., & Gersl, V. (2009). Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron. Pharmacological Reports, 61, 154-171.
34. Su, Y. W., Liang, C., Jin, H. F., Tang, X. Y., Han, W., Chai, L. J., et al. (2009). Hydrogen sulfide regulates cardiac function and structure in adriamycin-induced cardiomyopathy. Circulation Journal, 73, 741-749.
35. Iqbal, M., Dubey, K., Anwer, T., Ashish, A., & Pillai, K. K. (2008). Protective effects of telmisartan against acute doxorubi-cin-induced cardiotoxicity in rats. Pharmacological Reports, 60, 382-390.
36. L'Ecuyer, T., Sanjeev, S., Thomas, R., Novak, R., Das, L., Campbell, W., et al. (2006). DNA damage is an early event in doxorubicin-induced cardiac myocyte death. American Journal of Physiology, 291, H1273-H1280. (Pubitemid 44343672)
37. Chao, H. H., Liu, J. C., Hong, H. J., Lin, J. W., Chen, C. H., & Cheng, T. H. (2011). L-carnitine reduces doxorubicin-induced apoptosis through a prostacyclin-mediated pathway in neonatal rat cardiomyocytes. International Journal of Cardiology, 146, 145-152.
38. Li, N., & Karin, M. (1999). Is NF-kappaB the sensor of oxidative stress? The Faseb Journal, 13, 1137-1143.
39. Wang, S., Kotamraju, S., Konorev, E., Kalivendi, S., Joseph, J., & Kalyanaraman, B. (2002). Activation of nuclear factor-kappaB during doxorubicin-induced apoptosis in endothelial cells and myocytes is pro-apoptotic: The role of hydrogen peroxide. Biochemical Journal, 367, 729-740. (Pubitemid 35305712)
40. Liu, J., Mao, W., Ding, B., & Liang, C. S. (2008). ERKs/p53 signal transduction pathway is involved in doxorubicin-induced apoptosis in H9c2 cells and cardiomyocytes. American Journal of Physiology, 295, H1956-H1965.
41. Lou, H., Danelisen, I., & Singal, P. K. (2005). Involvement of mitogen-activated protein kinases in adriamycin-induced cardio-myopathy. American Journal of Physiology, 288, H1925-H1930. (Pubitemid 40418022)
42. Kim, J. Y., Jung, K. J., Choi, J. S., & Chung, H. Y. (2006). Modulation of the age-related nuclear factor-kappaB (NF-kappaB) pathway by hesperetin. Aging Cell, 5, 401-411. (Pubitemid 44322536)
43. Sardao, V. A., Oliveira, P. J., Holy, J., Oliveira, C. R., & Wallace, K. B. (2009). Morphological alterations induced by doxorubicin on H9c2 myoblasts: Nuclear, mitochondrial, and cytoskeletal targets. Cell Biology and Toxicology, 25, 227-243.
44. Zhang, S. H., Wang, W. Q., & Wang, J. L. (2009). Protective effect of tetrahydroxystilbene glucoside on cardiotoxicity induced by doxorubicin in vitro and in vivo. Acta Pharmacologica Sinica, 30, 1479-1487.
45. Hwang, S. L., & Yen, G. C. (2008). Neuroprotective effects of the citrus flavanones against H2O2-induced cytotoxicity in PC12 cells. Journal of Agricultural and Food Chemistry, 56, 859-864.
46. Choi, E. J., & Kim, G. H. (2011). Anti-/pro-apoptotic effects of hesperetin against 7, 12-dimetylbenz(a)anthracene-induced alteration in animals. Oncology Reports, 25, 545-550.
47. Ali, M. M., Agha, F. G., El-Sammad, N. M., & Hassan, S. K. (2009). Modulation of anticancer drug-induced P-glycoprotein expression by naringin. Zeitschrift für Naturforschung Section C, 64, 109-116.
48. Hsiao, Y. C., Hsieh, Y. S., Kuo, W. H., Chiou, H. L., Yang, S. F., Chiang, W. L., et al. (2007). The tumor-growth inhibitory activity of flavanone and 2-OH flavanone in vitro and in vivo through induction of cell cycle arrest and suppression of cyclins and CDKs. Journal of Biomedical Science, 14, 107-119.
49. Choi, E. J. (2007). Hesperetin induced G1-phase cell cycle arrest in human breast cancer MCF-7 cells: Involvement of CDK4 and p21. Nutrition and Cancer, 59, 115-119. (Pubitemid 47549789)
50. Masoodi, T. A., & Alhamdanz, A. H. (2010). Inhibitory effect of flavonoids on mutant H-Rasp protein. Bioinformation, 5, 11-15.